Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extimia vs Filgrastim for Neutropenia Prophylaxis in Breast Cancer
NCT01569087Phase 2Completed
- Sponsor
- BIOCAD
- Start
- May 2012
- Primary completion
- Jan 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of empegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by BIOCAD. Started May 2012; status: completed.
02
Drugs
empegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT01569087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569087.